Belize: Ministry of Health Confirms Quality Generic Medications
Belmopan. July 16, 2019. As part of its ongoing initiatives to provide quality healthcare medications, the Ministry of Health sent five different generic medications to the Caribbean Regional Public Health Agency’s (CARPHA) Drug Testing Laboratory, which is CARICOM’s regional reference laboratory for testing. The medications range from antibiotics to antidiabetic drugs that were sampled from the public sector.
All five medications have passed the quality tests performed as per international standards. This means that these generic medications are of confirmed quality.
The medications tested were:
|Product Name||Manufacturer||Batch No.||Expiry Date|
|Ciprofloxacin 500 mg tablets||GAMMA Laboratorios, El Salvador||C17100||03/2020|
|Glibenclamide 5 mg tablets||Generifar S.A., Nicaragua||271418||04/2021|
|Atenolol 50 mg tablets||Generifar S.A., Nicaragua||761418||04/2021|
|ACEVIRAL (Aciclovir) 400 mg caplet||Gefarca Industria Farmaceutica, Dominican Republic||197/17||07/2020|
|Amoxicillin 500 mg tablets||Reyoung Pharmaceutical Co. Ltd., China||163132189||9/2019|
The medications were selected based on a risk-based approach strategy which includes medications from the larger population and public health program. The Ministry remains committed in the continuous monitoring of pharmaceuticals and hereby seeks ongoing public engagement in reporting any suspicious medication to the Drug Inspectorate Unit at 828-4467 or via the firstname.lastname@example.org email.
For more information, contact:
Mrs. Danini Marin
Director – Drug Inspectorate Unit, Ministry of Health